Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Management of Diabetic Ketoacidosis in Children: Does Early Glargine Prevent Rebound Hyperglycemia?

NCT03107208 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT03107208
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03107208 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Management of Diabetic Ketoacidosis in Children: Does Early Glargine Prevent Rebound Hyperglycemia?
Lead sponsor
University of Colorado, Denver
Phase
Phase 4
Overall status
Completed
Start date
July 21, 2017
Completion date
March 13, 2021
Enrollment
61 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic ketoacidosis, type 1 diabetes mellitus